{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:43:11Z","timestamp":1792456991814,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12016-017-8639-y","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T20:43:29Z","timestamp":1504557809000},"page":"357-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Cutaneous and Mucosal Manifestations of Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.1007","volume":"53","author":[{"given":"Elena","family":"Generali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Mainetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-0376","authenticated-orcid":false,"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"8639_CR1","doi-asserted-by":"publisher","unstructured":"Maciel G, Crowson CS, Matteson EL, Cornec D (2016) Prevalence of primary Sjogren\u2019s syndrome in a population-based cohort in the United States. Arthritis Care Res (Hoboken). doi: 10.1002\/acr.23173","DOI":"10.1002\/acr.23173"},{"issue":"8","key":"8639_CR2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/0009922807301945","volume":"46","author":"M Civilibal","year":"2007","unstructured":"Civilibal M, Canpolat N, Yurt A, Kurugoglu S, Erdamar S, Bagci O, Sever L, Kasapcopur O, Caliskan S, Arisoy N (2007) A child with primary Sjogren syndrome and a review of the literature. Clin Pediatr (Phila) 46(8):738\u2013742. doi: 10.1177\/0009922807301945","journal-title":"Clin Pediatr (Phila)"},{"issue":"5","key":"8639_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MEG.0b013e328350f95b","volume":"24","author":"C Efe","year":"2012","unstructured":"Efe C, Wahlin S, Ozaslan E, Berlot AH, Purnak T, Muratori L, Quarneti C, Yuksel O, Thiefin G, Muratori P (2012) Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol 24(5):531\u2013534. doi: 10.1097\/MEG.0b013e328350f95b","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"8639_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jaut.2016.03.003","volume":"69","author":"J Ji","year":"2016","unstructured":"Ji J, Sundquist J, Sundquist K (2016) Gender-specific incidence of autoimmune diseases from national registers. J Autoimmun 69:102\u2013106. doi: 10.1016\/j.jaut.2016.03.003","journal-title":"J Autoimmun"},{"key":"8639_CR5","doi-asserted-by":"publisher","unstructured":"Vivino FB (2017) Sjogren\u2019s syndrome: clinical aspects. Clin Immunol. doi: 10.1016\/j.clim.2017.04.005","DOI":"10.1016\/j.clim.2017.04.005"},{"issue":"4","key":"8639_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.rdc.2008.08.009","volume":"34","author":"E Theander","year":"2008","unstructured":"Theander E, Jacobsson LT (2008) Relationship of Sjogren\u2019s syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin N Am 34(4):935\u2013947, viii-ix. doi: 10.1016\/j.rdc.2008.08.009","journal-title":"Rheum Dis Clin N Am"},{"key":"8639_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaut.2016.06.008","volume":"73","author":"GE Fragoulis","year":"2016","unstructured":"Fragoulis GE, Fragkioudaki S, Reilly JH, Kerr SC, McInnes IB, Moutsopoulos HM (2016) Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca syndrome. J Autoimmun 73:85\u201391. doi: 10.1016\/j.jaut.2016.06.008","journal-title":"J Autoimmun"},{"issue":"4","key":"8639_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jaut.2012.05.011","volume":"39","author":"CP Mavragani","year":"2012","unstructured":"Mavragani CP, Fragoulis GE, Moutsopoulos HM (2012) Endocrine alterations in primary Sjogren\u2019s syndrome: an overview. J Autoimmun 39(4):354\u2013358. doi: 10.1016\/j.jaut.2012.05.011","journal-title":"J Autoimmun"},{"issue":"3","key":"8639_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jaut.2012.05.008","volume":"39","author":"MJ Amador-Patarroyo","year":"2012","unstructured":"Amador-Patarroyo MJ, Arbelaez JG, Mantilla RD, Rodriguez-Rodriguez A, Cardenas-Roldan J, Pineda-Tamayo R, Guarin MR, Kleine LL, Rojas-Villarraga A, Anaya JM (2012) Sjogren\u2019s syndrome at the crossroad of polyautoimmunity. J Autoimmun 39(3):199\u2013205. doi: 10.1016\/j.jaut.2012.05.008","journal-title":"J Autoimmun"},{"issue":"Suppl 11","key":"8639_CR10","first-page":"S9","volume":"12","author":"FN Skopouli","year":"1994","unstructured":"Skopouli FN, Moutsopoulos HM (1994) Autoimmune epitheliitis: Sjogren\u2019s syndrome. Clin Exp Rheumatol 12(Suppl 11):S9\u201311","journal-title":"Clin Exp Rheumatol"},{"issue":"9777","key":"8639_CR11","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","volume":"377","author":"C Selmi","year":"2011","unstructured":"Selmi C, Bowlus CL, Gershwin ME, Coppel RL (2011) Primary biliary cirrhosis. Lancet 377(9777):1600\u20131609. doi: 10.1016\/S0140-6736(10)61965-4","journal-title":"Lancet"},{"key":"8639_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaut.2014.02.006","volume":"51","author":"D Cornec","year":"2014","unstructured":"Cornec D, Jamin C, Pers JO (2014) Sjogren\u2019s syndrome: where do we stand, and where shall we go? J Autoimmun 51:109\u2013114. doi: 10.1016\/j.jaut.2014.02.006","journal-title":"J Autoimmun"},{"issue":"7","key":"8639_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.autrev.2016.03.004","volume":"15","author":"AV Goules","year":"2016","unstructured":"Goules AV, Tzioufas AG (2016) Primary Sjgren\u2019s syndrome: clinical phenotypes, outcome and the development of biomarkers. Autoimmun Rev 15(7):695\u2013703. doi: 10.1016\/j.autrev.2016.03.004","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8639_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1046\/j.1365-2796.1996.482818000.x","volume":"239","author":"P Oxholm","year":"1996","unstructured":"Oxholm P, Asmussen K (1996) Primary Sjogren\u2019s syndrome: the challenge for classification of disease manifestations. J Intern Med 239(6):467\u2013474","journal-title":"J Intern Med"},{"issue":"1","key":"8639_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjogren's Syndrome Criteria Working G (2017) 2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69(1):35\u201345. doi: 10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"8639_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00296-017-3691-8","volume":"37","author":"Y Kabasakal","year":"2017","unstructured":"Kabasakal Y, Kitapcioglu G, Karabulut G, Tezcan M, Balkarli A, Aksoy A, Yavuz S, Yilmaz S, Kasifoglu T, Kalyoncu U, Dalkilic E, Tufan A, Mercan R, Yildiz F, Senturk T, Onen F, Bes C, Erken E, Tunc E, Kamali S, Tarhan E, Yazici A, Duzgun N, Bicakcigil M, Yilmaz S, Ozmen M, Ocal L, Alibaz-Oner F, Solmaz D, Cobankara V, Nalbant S, Kasapoglu Gunal E, Kaskari D, Goker B (2017) Criteria sets for primary Sjogren\u2019s syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features. Rheumatol Int 37(5):675\u2013684. doi: 10.1007\/s00296-017-3691-8","journal-title":"Rheumatol Int"},{"issue":"1","key":"8639_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjogren's Syndrome Criteria Working G (2017) 2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9\u201316. doi: 10.1136\/annrheumdis-2016-210571","journal-title":"Ann Rheum Dis"},{"key":"8639_CR18","doi-asserted-by":"publisher","unstructured":"Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG (2017) International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren\u2019s syndrome)?: the unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. doi: 10.1016\/j.autrev.2017.07.012","DOI":"10.1016\/j.autrev.2017.07.012"},{"issue":"2\u20133","key":"8639_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12016-015-8471-1","volume":"48","author":"Y Sun","year":"2015","unstructured":"Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin ME (2015) The coexistence of Sjogren\u2019s syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol 48(2\u20133):301\u2013315. doi: 10.1007\/s12016-015-8471-1","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1\u20132","key":"8639_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","volume":"39","author":"C Selmi","year":"2012","unstructured":"Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sjogren\u2019s syndrome: autoimmune epithelitis. J Autoimmun 39(1\u20132):34\u201342. doi: 10.1016\/j.jaut.2011.11.005","journal-title":"J Autoimmun"},{"key":"8639_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaut.2015.04.004","volume":"60","author":"B Chaigne","year":"2015","unstructured":"Chaigne B, Lasfargues G, Marie I, Huttenberger B, Lavigne C, Marchand-Adam S, Maillot F, Diot E (2015) Primary Sjogren\u2019s syndrome and occupational risk factors: a case-control study. J Autoimmun 60:80\u201385. doi: 10.1016\/j.jaut.2015.04.004","journal-title":"J Autoimmun"},{"issue":"4","key":"8639_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jaut.2012.05.007","volume":"39","author":"C Selmi","year":"2012","unstructured":"Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M, Rose NR, Gershwin ME (2012) Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 39(4):272\u2013284. doi: 10.1016\/j.jaut.2012.05.007","journal-title":"J Autoimmun"},{"issue":"5","key":"8639_CR23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-0039.1975.tb00653.x","volume":"6","author":"ME Gershwin","year":"1975","unstructured":"Gershwin ME, Terasaki I, Graw R, Chused TM (1975) Increased frequency of HL-A8 in Sjogren\u2019s syndrome. Tissue Antigens 6(5):342\u2013346","journal-title":"Tissue Antigens"},{"key":"8639_CR24","doi-asserted-by":"publisher","unstructured":"Teos LY, Alevizos I (2017) Genetics of Sjogren\u2019s syndrome. Clin Immunol. doi: 10.1016\/j.clim.2017.04.018","DOI":"10.1016\/j.clim.2017.04.018"},{"key":"8639_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2014.11.006","volume":"57","author":"R Huang","year":"2015","unstructured":"Huang R, Yin J, Chen Y, Deng F, Chen J, Gao X, Liu Z, Yu X, Zheng J (2015) The amino acid variation within the binding pocket 7 and 9 of HLA-DRB1 molecules are associated with primary Sjogren\u2019s syndrome. J Autoimmun 57:53\u201359. doi: 10.1016\/j.jaut.2014.11.006","journal-title":"J Autoimmun"},{"key":"8639_CR26","doi-asserted-by":"publisher","unstructured":"Chen K, Liu J, Cao X (2017) Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J Autoimmun. doi: 10.1016\/j.jaut.2017.03.008","DOI":"10.1016\/j.jaut.2017.03.008"},{"key":"8639_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","volume":"63","author":"A Nezos","year":"2015","unstructured":"Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, Crow MK, Mavragani CP (2015) Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis. J Autoimmun 63:47\u201358. doi: 10.1016\/j.jaut.2015.07.002","journal-title":"J Autoimmun"},{"key":"8639_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2016.08.001","volume":"74","author":"M Teruel","year":"2016","unstructured":"Teruel M, Alarcon-Riquelme ME (2016) The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun 74:161\u2013175. doi: 10.1016\/j.jaut.2016.08.001","journal-title":"J Autoimmun"},{"key":"8639_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jaut.2016.05.013","volume":"74","author":"PR Nielsen","year":"2016","unstructured":"Nielsen PR, Kragstrup TW, Deleuran BW, Benros ME (2016) Infections as risk factor for autoimmune diseases\u2014a nationwide study. J Autoimmun 74:176\u2013181. doi: 10.1016\/j.jaut.2016.05.013","journal-title":"J Autoimmun"},{"key":"8639_CR30","doi-asserted-by":"publisher","unstructured":"Watad A, Azrielant S, Bragazzi NL, Sharif K, David P, Katz I, Aljadeff G, Quaresma M, Tanay G, Adawi M, Amital H, Shoenfeld Y (2017) Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity. J Autoimmun. doi: 10.1016\/j.jaut.2017.06.001","DOI":"10.1016\/j.jaut.2017.06.001"},{"key":"8639_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","volume":"51","author":"S Kivity","year":"2014","unstructured":"Kivity S, Arango MT, Ehrenfeld M, Tehori O, Shoenfeld Y, Anaya JM, Agmon-Levin N (2014) Infection and autoimmunity in Sjogren\u2019s syndrome: a clinical study and comprehensive review. J Autoimmun 51:17\u201322. doi: 10.1016\/j.jaut.2014.02.008","journal-title":"J Autoimmun"},{"key":"8639_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jaut.2015.12.002","volume":"68","author":"OD Konsta","year":"2016","unstructured":"Konsta OD, Le Dantec C, Charras A, Cornec D, Kapsogeorgou EK, Tzioufas AG, Pers JO, Renaudineau Y (2016) Defective DNA methylation in salivary gland epithelial acini from patients with Sjogren\u2019s syndrome is associated with SSB gene expression, anti-SSB\/LA detection, and lymphocyte infiltration. J Autoimmun 68:30\u201338. doi: 10.1016\/j.jaut.2015.12.002","journal-title":"J Autoimmun"},{"key":"8639_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jaut.2013.02.001","volume":"42","author":"MJ Barrera","year":"2013","unstructured":"Barrera MJ, Bahamondes V, Sepulveda D, Quest AF, Castro I, Cortes J, Aguilera S, Urzua U, Molina C, Perez P, Ewert P, Alliende C, Hermoso MA, Gonzalez S, Leyton C, Gonzalez MJ (2013) Sjogren\u2019s syndrome and the epithelial target: a comprehensive review. J Autoimmun 42:7\u201318. doi: 10.1016\/j.jaut.2013.02.001","journal-title":"J Autoimmun"},{"issue":"4 Pt 1","key":"8639_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/hep.1840200418","volume":"20","author":"K Tsuneyama","year":"1994","unstructured":"Tsuneyama K, Van de Water J, Nakanuma Y, Cha S, Ansari A, Coppel R, Gershwin ME (1994) Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjogren\u2019s syndrome. Hepatology 20(4 Pt 1):893\u2013898","journal-title":"Hepatology"},{"issue":"8","key":"8639_CR35","first-page":"1552","volume":"24","author":"P Manganelli","year":"1997","unstructured":"Manganelli P, Quaini F, Andreoli AM, Lagrasta C, Pilato FP, Zuccarelli A, Monteverdi R, D'Aversa C, Olivetti G (1997) Quantitative analysis of apoptosis and bcl-2 in Sjogren\u2019s syndrome. J Rheumatol 24(8):1552\u20131557","journal-title":"J Rheumatol"},{"issue":"2","key":"8639_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/clin.1998.4556","volume":"88","author":"L Kong","year":"1998","unstructured":"Kong L, Ogawa N, McGuff HS, Nakabayashi T, Sakata KM, Masago R, Vela-Roch N, Talal N, Dang H (1998) Bcl-2 family expression in salivary glands from patients with primary Sjogren\u2019s syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol 88(2):133\u2013141","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"8639_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1365-3083.2002.01072_79.x","volume":"56","author":"M Ohlsson","year":"2002","unstructured":"Ohlsson M, Jonsson R, Brokstad KA (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjogren\u2019s syndrome. Scand J Immunol 56(5):456\u2013469","journal-title":"Scand J Immunol"},{"key":"8639_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2014.08.004","volume":"56","author":"GE Fragoulis","year":"2015","unstructured":"Fragoulis GE, Vakrakou AG, Papadopoulou A, Germenis A, Kanavakis E, Moutsopoulos HM, Manoussakis MN (2015) Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjogren\u2019s syndrome. J Autoimmun 56:12\u201322. doi: 10.1016\/j.jaut.2014.08.004","journal-title":"J Autoimmun"},{"issue":"2","key":"8639_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.cdd.4401517","volume":"12","author":"J Monks","year":"2005","unstructured":"Monks J, Rosner D, Geske FJ, Lehman L, Hanson L, Neville MC, Fadok VA (2005) Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 12(2):107\u2013114. doi: 10.1038\/sj.cdd.4401517","journal-title":"Cell Death Differ"},{"issue":"3","key":"8639_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","volume":"39","author":"N Singh","year":"2012","unstructured":"Singh N, Cohen PL (2012) The T cell in Sjogren\u2019s syndrome: force majeure, not spectateur. J Autoimmun 39(3):229\u2013233. doi: 10.1016\/j.jaut.2012.05.019","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"8639_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0168-8278(92)90024-J","volume":"15","author":"U Spengler","year":"1992","unstructured":"Spengler U, Moller A, Jung MC, Messer G, Zachoval R, Hoffmann RM, Eisenburg J, Paumgartner G, Riethmuller G, Weiss EH et al (1992) T lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lymphotoxin, tumor necrosis factor and interferon-gamma upon mitogen stimulation. J Hepatol 15(1\u20132):129\u2013135","journal-title":"J Hepatol"},{"key":"8639_CR42","doi-asserted-by":"publisher","unstructured":"Li S, Yang D, Peng T, Wu Y, Tian Z, Ni B (2017) Innate lymphoid cell-derived cytokines in autoimmune diseases. J Autoimmun. doi: 10.1016\/j.jaut.2017.05.001","DOI":"10.1016\/j.jaut.2017.05.001"},{"issue":"6","key":"8639_CR43","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","volume":"74","author":"X Lin","year":"2015","unstructured":"Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, Ko KH, Jiao Z, Chan VS, Lau CS, Cao X, Lu L (2015) Th17 cells play a critical role in the development of experimental Sjogren\u2019s syndrome. Ann Rheum Dis 74(6):1302\u20131310. doi: 10.1136\/annrheumdis-2013-204584","journal-title":"Ann Rheum Dis"},{"key":"8639_CR44","doi-asserted-by":"publisher","unstructured":"Matsui K, Sano H (2017) T helper 17 cells in primary Sjogren\u2019s syndrome. J Clin Med 6(7). doi: 10.3390\/jcm6070065","DOI":"10.3390\/jcm6070065"},{"key":"8639_CR45","doi-asserted-by":"publisher","first-page":"4768408","DOI":"10.1155\/2017\/4768408","volume":"2017","author":"Y Gan","year":"2017","unstructured":"Gan Y, Zhao X, He J, Liu X, Li Y, Sun X, Li Z (2017) Increased interleukin-17F is associated with elevated autoantibody levels and more clinically relevant than interleukin-17A in primary Sjogren\u2019s syndrome. J Immunol Res 2017:4768408. doi: 10.1155\/2017\/4768408","journal-title":"J Immunol Res"},{"issue":"3","key":"8639_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","volume":"39","author":"D Cornec","year":"2012","unstructured":"Cornec D, Devauchelle-Pensec V, Tobon GJ, Pers JO, Jousse-Joulin S, Saraux A (2012) B cells in Sjogren\u2019s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 39(3):161\u2013167. doi: 10.1016\/j.jaut.2012.05.014","journal-title":"J Autoimmun"},{"issue":"9","key":"8639_CR47","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.autrev.2010.05.006","volume":"9","author":"MM Varin","year":"2010","unstructured":"Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO (2010) B-cell tolerance breakdown in Sjogren\u2019s syndrome: focus on BAFF. Autoimmun Rev 9(9):604\u2013608. doi: 10.1016\/j.autrev.2010.05.006","journal-title":"Autoimmun Rev"},{"issue":"13","key":"8639_CR48","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1177\/0961203314546023","volume":"23","author":"F Carubbi","year":"2014","unstructured":"Carubbi F, Alunno A, Cipriani P, Bartoloni E, Ciccia F, Triolo G, Gerli R, Giacomelli R (2014) Rituximab in primary Sjogren\u2019s syndrome: a ten-year journey. Lupus 23(13):1337\u20131349. doi: 10.1177\/0961203314546023","journal-title":"Lupus"},{"issue":"4","key":"8639_CR49","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H (2010) Effectiveness of rituximab treatment in primary Sjogren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62(4):960\u2013968. doi: 10.1002\/art.27314","journal-title":"Arthritis Rheum"},{"key":"8639_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2017.03.012","volume":"81","author":"EA Haacke","year":"2017","unstructured":"Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM, Kroese FGM (2017) FcRL4+ B-cells in salivary glands of primary Sjogren\u2019s syndrome patients. J Autoimmun 81:90\u201398. doi: 10.1016\/j.jaut.2017.03.012","journal-title":"J Autoimmun"},{"issue":"3","key":"8639_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-005-4091-5","volume":"25","author":"MV Jonsson","year":"2005","unstructured":"Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K (2005) Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren\u2019s syndrome. J Clin Immunol 25(3):189\u2013201. doi: 10.1007\/s10875-005-4091-5","journal-title":"J Clin Immunol"},{"key":"8639_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","volume":"51","author":"L Quartuccio","year":"2014","unstructured":"Quartuccio L, Isola M, Baldini C, Priori R, Bartoloni Bocci E, Carubbi F, Maset M, Gregoraci G, Della Mea V, Salvin S, De Marchi G, Luciano N, Colafrancesco S, Alunno A, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S (2014) Biomarkers of lymphoma in Sjogren\u2019s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J Autoimmun 51:75\u201380. doi: 10.1016\/j.jaut.2013.10.002","journal-title":"J Autoimmun"},{"issue":"1","key":"8639_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/cei.12869","volume":"187","author":"A Globinska","year":"2017","unstructured":"Globinska A, Pawelczyk M, Piechota-Polanczyk A, Olszewska-Ziaber A, Moskwa S, Mikolajczyk A, Jablonska A, Zakrzewski PK, Brauncajs M, Jarzebska M, Taka S, Papadopoulos NG, Kowalski ML (2017) Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis. Clin Exp Immunol 187(1):100\u2013112. doi: 10.1111\/cei.12869","journal-title":"Clin Exp Immunol"},{"key":"8639_CR54","doi-asserted-by":"publisher","unstructured":"Zhang C, Tian Z (2017) NK cell subsets in autoimmune diseases. J Autoimmun. doi: 10.1016\/j.jaut.2017.02.005","DOI":"10.1016\/j.jaut.2017.02.005"},{"issue":"1","key":"8639_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jdermsci.2005.01.017","volume":"39","author":"E Bernacchi","year":"2005","unstructured":"Bernacchi E, Bianchi B, Amato L, Giorgini S, Fabbri P, Tavoni A, Bombardieri S (2005) Xerosis in primary Sjogren syndrome: immunohistochemical and functional investigations. J Dermatol Sci 39(1):53\u201355. doi: 10.1016\/j.jdermsci.2005.01.017","journal-title":"J Dermatol Sci"},{"issue":"5","key":"8639_CR56","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1365-2133.1995.tb02744.x","volume":"133","author":"I Katayama","year":"1995","unstructured":"Katayama I, Yokozeki H, Nishioka K (1995) Impaired sweating as an exocrine manifestation in Sjogren\u2019s syndrome. Br J Dermatol 133(5):716\u2013720","journal-title":"Br J Dermatol"},{"key":"8639_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000446780","volume":"51","author":"I Katayama","year":"2016","unstructured":"Katayama I (2016) Abberant sudomotor functions in Sjogren\u2019s syndrome: comparable study with atopic dermatitis on dry skin manifestation. Curr Probl Dermatol 51:62\u201374. doi: 10.1159\/000446780","journal-title":"Curr Probl Dermatol"},{"issue":"3","key":"8639_CR58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0889-857X(21)00319-7","volume":"18","author":"TT Provost","year":"1992","unstructured":"Provost TT, Watson R (1992) Cutaneous manifestations of Sjogren\u2019s syndrome. Rheum Dis Clin N Am 18(3):609\u2013616","journal-title":"Rheum Dis Clin N Am"},{"issue":"1","key":"8639_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clindermatol.2013.05.035","volume":"32","author":"R Wolf","year":"2014","unstructured":"Wolf R, Orion E, Tuzun Y (2014) Periorbital (eyelid) dermatides. Clin Dermatol 32(1):131\u2013140. doi: 10.1016\/j.clindermatol.2013.05.035","journal-title":"Clin Dermatol"},{"key":"8639_CR60","doi-asserted-by":"publisher","unstructured":"Chisholm SA, Couch SM, Custer PL (2016) Etiology and management of allergic eyelid dermatitis. Ophthal Plast Reconstr Surg. doi: 10.1097\/IOP.0000000000000723","DOI":"10.1097\/IOP.0000000000000723"},{"issue":"1","key":"8639_CR61","first-page":"55","volume":"22","author":"E Bernacchi","year":"2004","unstructured":"Bernacchi E, Amato L, Parodi A, Cottoni F, Rubegni P, De Pita O, Papini M, Rebora A, Bombardieri S, Fabbri P (2004) Sjogren\u2019s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian group of immunodermatology. Clin Exp Rheumatol 22(1):55\u201362","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"8639_CR62","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-4362.1994.tb04044.x","volume":"33","author":"I Katayama","year":"1994","unstructured":"Katayama I, Koyano T, Nishioka K (1994) Prevalence of eyelid dermatitis in primary Sjogren\u2019s syndrome. Int J Dermatol 33(6):421\u2013424","journal-title":"Int J Dermatol"},{"issue":"8","key":"8639_CR63","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/1346-8138.13300","volume":"43","author":"N Takeo","year":"2016","unstructured":"Takeo N, Sakai T, Saito-Shono T, Ishikawa K, Hatano Y, Katagiri K, Takahashi Y, Kawano K, Kimoto K, Kubota T, Eshima N, Kojima H, Fujiwara S (2016) Three cases of pigmented cosmetic dermatitis-like eruptions associated with primary Sjogren\u2019s syndrome or anti-SSA antibody. J Dermatol 43(8):947\u2013950. doi: 10.1111\/1346-8138.13300","journal-title":"J Dermatol"},{"issue":"12","key":"8639_CR64","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals M, Brito-Zeron P, Seror R, Bootsma H, Bowman SJ, Dorner T, Gottenberg JE, Mariette X, Theander E, Bombardieri S, De Vita S, Mandl T, Ng WF, Kruize A, Tzioufas A, Vitali C, Force ESST (2015) Characterization of systemic disease in primary Sjogren\u2019s syndrome: EULAR-SS task force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 54(12):2230\u20132238. doi: 10.1093\/rheumatology\/kev200","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"8639_CR65","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semarthrit.2006.08.007","volume":"36","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zeron P, Font J (2007) The overlap of Sjogren\u2019s syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum 36(4):246\u2013255. doi: 10.1016\/j.semarthrit.2006.08.007","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"8639_CR66","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dorner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ, EULAR Sj\u00f6gren\u2019s Task Force (2011) EULAR Sjogren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 70(6):968\u2013972. doi: 10.1136\/ard.2010.143743","journal-title":"Ann Rheum Dis"},{"key":"8639_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaut.2013.12.010","volume":"51","author":"R Seror","year":"2014","unstructured":"Seror R, Theander E, Bootsma H, Bowman SJ, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dorner T, Ravaud P, Mariette X, Vitali C (2014) Outcome measures for primary Sjogren\u2019s syndrome: a comprehensive review. J Autoimmun 51:51\u201356. doi: 10.1016\/j.jaut.2013.12.010","journal-title":"J Autoimmun"},{"issue":"2","key":"8639_CR68","first-page":"289","volume":"64","author":"S Hsu","year":"2001","unstructured":"Hsu S, Le EH, Khoshevis MR (2001) Differential diagnosis of annular lesions. Am Fam Physician 64(2):289\u2013296","journal-title":"Am Fam Physician"},{"issue":"1","key":"8639_CR69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2310\/7750.2010.09033","volume":"15","author":"A Kittridge","year":"2011","unstructured":"Kittridge A, Routhouska SB, Korman NJ (2011) Dermatologic manifestations of Sjogren syndrome. J Cutan Med Surg 15(1):8\u201314. doi: 10.2310\/7750.2010.09033","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"8639_CR70","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","volume":"83","author":"M Ramos-Casals","year":"2004","unstructured":"Ramos-Casals M, Anaya JM, Garcia-Carrasco M, Rosas J, Bove A, Claver G, Diaz LA, Herrero C, Font J (2004) Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 83(2):96\u2013106","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"8639_CR71","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4049\/jimmunol.123.3.1382","volume":"123","author":"TJ Lawley","year":"1979","unstructured":"Lawley TJ, Moutsopoulos HM, Katz SI, Theofilopoulos AN, Chused TM, Frank MM (1979) Demonstration of circulating immune complexes in Sjogren\u2019s syndrome. J Immunol 123(3):1382\u20131387","journal-title":"J Immunol"},{"issue":"5","key":"8639_CR72","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/1523-1747.ep12552002","volume":"80","author":"EL Alexander","year":"1983","unstructured":"Alexander EL, Provost TT (1983) Cutaneous manifestations of primary Sjogren\u2019s syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies. J Invest Dermatol 80(5):386\u2013391","journal-title":"J Invest Dermatol"},{"issue":"4\u20135","key":"8639_CR73","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.autrev.2014.01.027","volume":"13","author":"J Damoiseaux","year":"2014","unstructured":"Damoiseaux J (2014) The diagnosis and classification of the cryoglobulinemic syndrome. Autoimmun Rev 13(4\u20135):359\u2013362. doi: 10.1016\/j.autrev.2014.01.027","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8639_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/BOR.0000000000000346","volume":"29","author":"C Demirkesen","year":"2017","unstructured":"Demirkesen C (2017) Approach to cutaneous vasculitides with special emphasis on small vessel vasculitis: histopathology and direct immunofluorescence. Curr Opin Rheumatol 29(1):39\u201344. doi: 10.1097\/BOR.0000000000000346","journal-title":"Curr Opin Rheumatol"},{"key":"8639_CR75","doi-asserted-by":"publisher","unstructured":"Quartuccio L, Baldini C, Priori R, Bartoloni E, Carubbi F, Alunno A, Gandolfo S, Colafrancesco S, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S, the GG (2017) Cryoglobulinemia in Sjogren syndrome: a disease subset that links higher systemic disease activity, autoimmunity, and local B cell proliferation in mucosa-associated lymphoid tissue. J Rheumatol. doi: 10.3899\/jrheum.161465","DOI":"10.3899\/jrheum.161465"},{"issue":"8","key":"8639_CR76","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/rheumatology\/kew194","volume":"55","author":"S Retamozo","year":"2016","unstructured":"Retamozo S, Gheitasi H, Quartuccio L, Kostov B, Corazza L, Bove A, Siso-Almirall A, Gandia M, Ramos-Casals M, De Vita S, Brito-Zeron P (2016) Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjogren syndrome: analysis of 515 patients. Rheumatology (Oxford) 55(8):1443\u20131451. doi: 10.1093\/rheumatology\/kew194","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"8639_CR77","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.autrev.2015.04.009","volume":"14","author":"D Guellec","year":"2015","unstructured":"Guellec D, Cornec-Le Gall E, Groh M, Hachulla E, Karras A, Charles P, Dunogue B, Abad S, Alvarez F, Gerard F, Devauchelle-Pensec V, Pers JO, Puechal X, Guillevin L, Saraux A, Cornec D, Cri, the French Vasculitis Study G (2015) ANCA-associated vasculitis in patients with primary Sjogren\u2019s syndrome: detailed analysis of 7 new cases and systematic literature review. Autoimmun Rev 14(8):742\u2013750. doi: 10.1016\/j.autrev.2015.04.009","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8639_CR78","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/art.23617","volume":"58","author":"JM Meijer","year":"2008","unstructured":"Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, Perfetti V, Leijsma MK, Bootsma H, Hazenberg BP (2008) Sjogren\u2019s syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum 58(7):1992\u20131999. doi: 10.1002\/art.23617","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8639_CR79","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1346-8138.2002.tb00244.x","volume":"29","author":"T Yamamoto","year":"2002","unstructured":"Yamamoto T, Ohi M, Nishioka K (2002) Lymphomatoid papulosis associated with Sjogren\u2019s syndrome. J Dermatol 29(3):174\u2013177","journal-title":"J Dermatol"},{"key":"8639_CR80","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/PPA.S132751","volume":"11","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Wang X, Chen H, Shen B (2017) Sjogren\u2019s syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from Short Form 36 questionnaire and a meta-analysis. Patient Prefer Adherence 11:905\u2013911. doi: 10.2147\/PPA.S132751","journal-title":"Patient Prefer Adherence"},{"issue":"7","key":"8639_CR81","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/ard.58.7.423","volume":"58","author":"M Pertovaara","year":"1999","unstructured":"Pertovaara M, Korpela M, Uusitalo H, Pukander J, Miettinen A, Helin H, Pasternack A (1999) Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Ann Rheum Dis 58(7):423\u2013427","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8639_CR82","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s40496-016-0112-0","volume":"3","author":"AI Bolstad","year":"2016","unstructured":"Bolstad AI, Skarstein K (2016) Epidemiology of Sjogren\u2019s syndrome-from an oral perspective. Curr Oral Health Rep 3(4):328\u2013336. doi: 10.1007\/s40496-016-0112-0","journal-title":"Curr Oral Health Rep"},{"issue":"5","key":"8639_CR83","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2012.10.018","volume":"12","author":"I Castro","year":"2013","unstructured":"Castro I, Sepulveda D, Cortes J, Quest AF, Barrera MJ, Bahamondes V, Aguilera S, Urzua U, Alliende C, Molina C, Gonzalez S, Hermoso MA, Leyton C, Gonzalez MJ (2013) Oral dryness in Sjogren\u2019s syndrome patients. Not just a question of water. Autoimmun Rev 12(5):567\u2013574. doi: 10.1016\/j.autrev.2012.10.018","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8639_CR84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5114\/pdia.2016.57764","volume":"33","author":"K Blochowiak","year":"2016","unstructured":"Blochowiak K, Olewicz-Gawlik A, Polanska A, Nowak-Gabryel M, Kociecki J, Witmanowski H, Sokalski J (2016) Oral mucosal manifestations in primary and secondary Sjogren syndrome and dry mouth syndrome. Postepy Dermatol Alergol 33(1):23\u201327. doi: 10.5114\/pdia.2016.57764","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"8639_CR85","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12016-014-8431-1","volume":"49","author":"D Cornec","year":"2015","unstructured":"Cornec D, Saraux A, Jousse-Joulin S, Pers JO, Boisrame-Gastrin S, Renaudineau Y, Gauvin Y, Roguedas-Contios AM, Genestet S, Chastaing M, Cochener B, Devauchelle-Pensec V (2015) The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review. Clin Rev Allergy Immunol 49(3):278\u2013287. doi: 10.1007\/s12016-014-8431-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"8639_CR86","doi-asserted-by":"publisher","first-page":"781683","DOI":"10.1155\/2014\/781683","volume":"2014","author":"A Sharma","year":"2014","unstructured":"Sharma A, Hindman HB (2014) Aging: a predisposition to dry eyes. J Ophthalmol 2014:781683. doi: 10.1155\/2014\/781683","journal-title":"J Ophthalmol"},{"issue":"6","key":"8639_CR87","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10792-014-9969-x","volume":"34","author":"A Yagci","year":"2014","unstructured":"Yagci A, Gurdal C (2014) The role and treatment of inflammation in dry eye disease. Int Ophthalmol 34(6):1291\u20131301. doi: 10.1007\/s10792-014-9969-x","journal-title":"Int Ophthalmol"},{"issue":"2","key":"8639_CR88","first-page":"240","volume":"9","author":"M Hessen","year":"2014","unstructured":"Hessen M, Akpek EK (2014) Dry eye: an inflammatory ocular disease. J Ophthalmic Vis Res 9(2):240\u2013250","journal-title":"J Ophthalmic Vis Res"},{"issue":"3","key":"8639_CR89","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12016-015-8518-3","volume":"49","author":"E Generali","year":"2015","unstructured":"Generali E, Cantarini L, Selmi C (2015) Ocular involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol 49(3):263\u2013270. doi: 10.1007\/s12016-015-8518-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"8639_CR90","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","volume":"51","author":"NC Kyriakidis","year":"2014","unstructured":"Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG (2014) A comprehensive review of autoantibodies in primary Sjogren\u2019s syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun 51:67\u201374. doi: 10.1016\/j.jaut.2013.11.001","journal-title":"J Autoimmun"},{"key":"8639_CR91","doi-asserted-by":"publisher","unstructured":"Shen L, Suresh L (2017) Autoantibodies, detection methods and panels for diagnosis of Sjogren\u2019s syndrome. Clin Immunol. doi: 10.1016\/j.clim.2017.03.017","DOI":"10.1016\/j.clim.2017.03.017"},{"issue":"1","key":"8639_CR92","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.berh.2016.04.003","volume":"30","author":"M Rischmueller","year":"2016","unstructured":"Rischmueller M, Tieu J, Lester S (2016) Primary Sjogren\u2019s syndrome. Best Pract Res Clin Rheumatol 30(1):189\u2013220. doi: 10.1016\/j.berh.2016.04.003","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"8639_CR93","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","volume":"73","author":"AP Risselada","year":"2014","unstructured":"Risselada AP, Kruize AA, Goldschmeding R, Lafeber FP, Bijlsma JW, van Roon JA (2014) The prognostic value of routinely performed minor salivary gland assessments in primary Sjogren\u2019s syndrome. Ann Rheum Dis 73(8):1537\u20131540. doi: 10.1136\/annrheumdis-2013-204634","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8639_CR94","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/ard.2010.144782","volume":"70","author":"E Theander","year":"2011","unstructured":"Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, Brokstad K, Jonsson R, Jonsson MV (2011) Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren\u2019s syndrome. Ann Rheum Dis 70(8):1363\u20131368. doi: 10.1136\/ard.2010.144782","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8639_CR95","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7150\/ijms.17718","volume":"14","author":"T Both","year":"2017","unstructured":"Both T, Dalm VA, van Hagen PM, van Daele PL (2017) Reviewing primary Sjogren\u2019s syndrome: beyond the dryness\u2014from pathophysiology to diagnosis and treatment. Int J Med Sci 14(3):191\u2013200. doi: 10.7150\/ijms.17718","journal-title":"Int J Med Sci"},{"issue":"1","key":"8639_CR96","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.coms.2013.09.009","volume":"26","author":"JJ Wu","year":"2014","unstructured":"Wu JJ, Carsons SE (2014) Management of extraglandular manifestations of primary Sjogren\u2019s syndrome. Oral Maxillofac Surg Clin North Am 26(1):101\u2013109. doi: 10.1016\/j.coms.2013.09.009","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"3","key":"8639_CR97","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12016-014-8438-7","volume":"49","author":"V Valim","year":"2015","unstructured":"Valim V, Trevisani VF, de Sousa JM, Vilela VS, Belfort R Jr (2015) Current approach to dry eye disease. Clin Rev Allergy Immunol 49(3):288\u2013297. doi: 10.1007\/s12016-014-8438-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"8639_CR98","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4137\/OED.S16067","volume":"6","author":"C Schultz","year":"2014","unstructured":"Schultz C (2014) Safety and efficacy of cyclosporine in the treatment of chronic dry eye. Ophthalmol Eye Dis 6:37\u201342. doi: 10.4137\/OED.S16067","journal-title":"Ophthalmol Eye Dis"},{"issue":"3","key":"8639_CR99","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan KH, Chen LJ, Young AL (2015) Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13(3):213\u2013225. doi: 10.1016\/j.jtos.2014.12.006","journal-title":"Ocul Surf"},{"key":"8639_CR100","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.12659\/MSM.891364","volume":"20","author":"A Liu","year":"2014","unstructured":"Liu A, Ji J (2014) Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies. Med Sci Monit 20:1583\u20131589. doi: 10.12659\/MSM.891364","journal-title":"Med Sci Monit"},{"issue":"4","key":"8639_CR101","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/ICU.0000000000000169","volume":"26","author":"JL Alio","year":"2015","unstructured":"Alio JL, Rodriguez AE, WrobelDudzinska D (2015) Eye platelet-rich plasma in the treatment of ocular surface disorders. Curr Opin Ophthalmol 26(4):325\u2013332. doi: 10.1097\/ICU.0000000000000169","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"8639_CR102","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/ICU.0000000000000171","volume":"26","author":"JC Bavinger","year":"2015","unstructured":"Bavinger JC, DeLoss K, Mian SI (2015) Scleral lens use in dry eye syndrome. Curr Opin Ophthalmol 26(4):319\u2013324. doi: 10.1097\/ICU.0000000000000171","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"8639_CR103","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0002-9394(00)00378-0","volume":"130","author":"T Romero-Rangel","year":"2000","unstructured":"Romero-Rangel T, Stavrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS (2000) Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol 130(1):25\u201332","journal-title":"Am J Ophthalmol"},{"key":"8639_CR104","doi-asserted-by":"publisher","first-page":"CD008934","DOI":"10.1002\/14651858.CD008934.pub2","volume":"12","author":"S Furness","year":"2011","unstructured":"Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R (2011) Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev 12:CD008934. doi: 10.1002\/14651858.CD008934.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"8639_CR105","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.2010.1014","volume":"304","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Tzioufas AG, Stone JH, Siso A, Bosch X (2010) Treatment of primary Sjogren syndrome: a systematic review. JAMA 304(4):452\u2013460. doi: 10.1001\/jama.2010.1014","journal-title":"JAMA"},{"issue":"2","key":"8639_CR106","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"FB Vivino","year":"1999","unstructured":"Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL 3rd, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159(2):174\u2013181","journal-title":"Arch Intern Med"},{"issue":"3","key":"8639_CR107","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Puechal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zarnitsky C, Batouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X (2014) Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial. JAMA 312(3):249\u2013258. doi: 10.1001\/jama.2014.7682","journal-title":"JAMA"},{"issue":"1","key":"8639_CR108","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12891-017-1543-z","volume":"18","author":"SQ Wang","year":"2017","unstructured":"Wang SQ, Zhang LW, Wei P, Hua H (2017) Is hydroxychloroquine effective in treating primary Sjogren\u2019s syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord 18(1):186. doi: 10.1186\/s12891-017-1543-z","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"8639_CR109","first-page":"555","volume":"14","author":"FN Skopouli","year":"1996","unstructured":"Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM (1996) Methotrexate in primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 14(5):555\u2013558","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"8639_CR110","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","volume":"72","author":"JE Gottenberg","year":"2013","unstructured":"Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, Sibilia J, Zarnitsky C, Carli P, Rist S, Gaudin P, Salliot C, Piperno M, Deplas A, Breban M, Lequerre T, Richette P, Ghiringhelli C, Hamidou M, Ravaud P, Mariette X, Club Rhumatismes et I, the French Society of R (2013) Efficacy of rituximab in systemic manifestations of primary Sjogren\u2019s syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis 72(6):1026\u20131031. doi: 10.1136\/annrheumdis-2012-202293","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8639_CR111","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/M13-1085","volume":"160","author":"V Devauchelle-Pensec","year":"2014","unstructured":"Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puechal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Pers JO, Nowak E, Saraux A (2014) Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med 160(4):233\u2013242. doi: 10.7326\/M13-1085","journal-title":"Ann Intern Med"},{"key":"8639_CR112","doi-asserted-by":"publisher","unstructured":"Bowman SJ, Everett CC, O\u2019Dwyer JL, Emery P, Pitzalis C, Ng WF, Pease CT, Price EJ, Sutcliffe N, St Gendi N, Hall FC, Ruddock SP, Fernandez C, Reynolds C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Giles IP, Sharples LD, Bombardieri M (2017) Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjogren\u2019s syndrome. Arthritis Rheumatol. doi: 10.1002\/art.40093","DOI":"10.1002\/art.40093"},{"issue":"12","key":"8639_CR113","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/rheumatology\/kev257","volume":"54","author":"S Vita De","year":"2015","unstructured":"De Vita S, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X (2015) Efficacy and safety of belimumab given for 12 months in primary Sjogren\u2019s syndrome: the BELISS open-label phase II study. Rheumatology (Oxford) 54(12):2249\u20132256. doi: 10.1093\/rheumatology\/kev257","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"8639_CR114","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3109\/14397595.2016.1158773","volume":"26","author":"H Tsuboi","year":"2016","unstructured":"Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Yagishita M, Takahashi H, Kurata I, Ohyama A, Honda F, Asashima H, Miki H, Umeda N, Kondo Y, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T (2016) Effectiveness of abatacept for patients with Sjogren\u2019s syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren\u2019s syndrome Endocrinopathy) trial. Mod Rheumatol 26(6):891\u2013899. doi: 10.3109\/14397595.2016.1158773","journal-title":"Mod Rheumatol"},{"issue":"7","key":"8639_CR115","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","volume":"73","author":"PM Meiners","year":"2014","unstructured":"Meiners PM, Vissink A, Kroese FG, Spijkervet FK, Smitt-Kamminga NS, Abdulahad WH, Bulthuis-Kuiper J, Brouwer E, Arends S, Bootsma H (2014) Abatacept treatment reduces disease activity in early primary Sjogren\u2019s syndrome (open-label proof of concept ASAP study). Ann Rheum Dis 73(7):1393\u20131396. doi: 10.1136\/annrheumdis-2013-204653","journal-title":"Ann Rheum Dis"},{"key":"8639_CR116","doi-asserted-by":"publisher","unstructured":"Schreiber K, Nocturne G, Cornec D, Daien CI (2017) Lymphocytes as biomarkers of therapeutic response in rheumatic autoimmune diseases, is it a realistic goal? Clin Rev Allergy Immunol. doi: 10.1007\/s12016-017-8614-7","DOI":"10.1007\/s12016-017-8614-7"},{"key":"8639_CR117","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jaut.2015.11.002","volume":"67","author":"D Cornec","year":"2016","unstructured":"Cornec D, Costa S, Devauchelle-Pensec V, Jousse-Joulin S, Marcorelles P, Berthelot JM, Chiche L, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Saraux A, Pers JO (2016) Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjogren\u2019s syndrome. J Autoimmun 67:102\u2013110. doi: 10.1016\/j.jaut.2015.11.002","journal-title":"J Autoimmun"},{"issue":"3","key":"8639_CR118","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/1759720X10363246","volume":"2","author":"C Vitali","year":"2010","unstructured":"Vitali C, Palombi G, Cataleta P (2010) Treating Sjogren\u2019s syndrome: insights for the clinician. Ther Adv Musculoskelet Dis 2(3):155\u2013166. doi: 10.1177\/1759720X10363246","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"8639_CR119","first-page":"1032","volume":"25","author":"P Durez","year":"1998","unstructured":"Durez P, Tourne L, Feremans W, Mascart-Lemone F, Heenen M, Appelboom T (1998) Dramatic response to intravenous high dose gamma-globulin in refractory vasculitis of the skin associated with Sjogren\u2019s syndrome. J Rheumatol 25(5):1032\u20131033","journal-title":"J Rheumatol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8639-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T18:16:56Z","timestamp":1719425816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8639-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["8639"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8639-y","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]}}}